Tranexamic Acid Improves Memory and Learning Abilities in Aging Mice

References

• McEntee WJ, Crook TH. Glutamate: its role in learning, memory, and the aging brain. Psychopharmacology. 1993;111(4):391–401.
   PubMed Web of Science ®Google Scholar
• Papenberg G, Li S-C, Nagel IE, et al. Dopamine and glutamate receptor genes interactively influence episodic memory in old age. Neurobiol Aging. 2014;35(5):1213. doi:10.1016/j.neurobiolaging.2013.11.014
   Web of Science ®Google Scholar
• Nyberg L, Karalija N, Salami A, et al. Dopamine D2 receptor availability is linked to hippocampal-caudate functional connectivity and episodic memory. Proc Natl Acad Sci U S A. 2016;113(28):7918–7923.
   PubMed Web of Science ®Google Scholar
• Morrison JH, Hof PR. Life and death of neurons in the aging brain. Science. 1997;278:412–419.
   PubMed Web of Science ®Google Scholar
• Giannakopoulos P, Herrmann FR, Bussiere T, et al. Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease. Neurology. 2003;60:1495–1500.
   PubMed Web of Science ®Google Scholar
• Jiang CH, Tsien JZ, Schultz PG, Hu Y. The effects of aging on gene expression in the hypothalamus and cortex of mice. Proc Natl Acad Sci USA. 2001;98(4):1930–1934.
   PubMed Web of Science ®Google Scholar
• Lu T, Pan Y, Kao A-Y, et al. Gene regulation and DNA damage in the ageing human brain. Nature. 2004;429(6994):883–891.
   PubMed Web of Science ®Google Scholar
• Yamazaki D, Horiuchi J, Ueno K, et al. Glial dysfunction causes age-related memory impairment in Drosophila. Neuron. 2014;84(4):753–763.
   Web of Science ®Google Scholar
• Becher E, Orellana Rios CL, Lahmann C, et al. Anxiety as a risk factor of Alzheimer’s disease and vascular dementia. Br J Psychiatry. 2018;213(5):654–660.
   Web of Science ®Google Scholar
• Shabir O, Berwick J, Francis SE. Neurovascular dysfunction in vascular dementia, Alzheimer’s and atherosclerosis. BMC Neurosci. 2018;19(1):62. doi:10.1186/s12868-018-0465-5
   Web of Science ®Google Scholar
• Blennow K, de Leon MJ, Zetterberg H. Alzheimer’s disease. Lancet. 2006;368(9533):387–403. doi:10.1016/S0140-6736(06)69113-7
   PubMed Web of Science ®Google Scholar
• Gouras GK, Almeida CG, Takahashi RH. Intraneuronal Aβ accumulation and origin of plaques in Alzheimer’s disease. Neurobiol Aging. 2005;26(9):1235–1244. doi:10.1016/j.neurobiolaging.2005.05.022
   PubMed Web of Science ®Google Scholar
• Holtzman DM, Morris JC, Goate AM. Alzheimer’s Disease: the Challenge of the Second Century. Sci Trans Med. 2011;3(77):77sr1. doi:10.1126/scitranslmed.3002369
   PubMed Web of Science ®Google Scholar
• Karran E, Mercken M, De Strooper B. The amyloid cascade hypothesis for Alzheimer’s disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov. 2011;10(9):698–712.
   PubMed Web of Science ®Google Scholar
• Francis PT, Palmer AM, Snape M, Wilcock GK. The cholinergic hypothesis of Alzheimer’s disease: a review of progress. J Neurol Neurosurg Psychiatry. 1999;66(2):137–147. doi:10.1136/jnnp.66.2.137
   PubMed Web of Science ®Google Scholar
• Merrill JE, Ignarro LJ, Sherman MP, Melinek J, Lane TE. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol. 1993;151(4):2132–2141.
   PubMed Web of Science ®Google Scholar
• Li J, Baud O, Vartanian T, Volpe JJ, Rosenberg PA. Peroxynitrite generated by inducible nitric oxide synthase and NADPH oxidase mediates microglial toxicity to oligodendrocytes. Proc Natl Acad Sci U S A. 2005;102(28):9936–9941. doi:10.1073/pnas.0502552102
   Web of Science ®Google Scholar
• Anisman H. Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder. J Psychiatry Neurosci. 2009;34(1):4–20.
   PubMed Web of Science ®Google Scholar
• Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 2009;65(9):732–741. doi:10.1016/j.biopsych.2008.11.029
   PubMed Web of Science ®Google Scholar
• Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67(5):446–457. doi:10.1016/j.biopsych.2009.09.033
   PubMed Web of Science ®Google Scholar
• Okunishi K, Sisson TH, Huang SK, et al. Plasmin Overcomes Resistance to Prostaglandin E 2 in Fibrotic Lung Fibroblasts by Reorganizing Protein Kinase A Signaling. J Biol Chem. 2011;286(37):32231–32243. doi:10.1074/jbc.M111.235606
   Web of Science ®Google Scholar
• Isseroff RR, Rifkin DB. Plasminogen is present in the basal layer of the epidermis. J Invest Dermatol. 1983;80(4):297–299. doi:10.1111/1523-1747.ep12534677
   Web of Science ®Google Scholar
• Hiramoto K, Yamate Y, Sugiyama D, Matsuda K, Iizuka Y, Yamaguchi T. Tranexamic acid inhibits the plasma and non-irradiated skin markers of photoaging induced by long-term UVA eye irradiation in female mice. Biomed Pharmacother. 2018;107:54–58. doi:10.1016/j.biopha.2018.07.146
   Web of Science ®Google Scholar
• Hiramoto K, Yamate Y, Sugiyama D, et al. Effect of tranexamic acid in improving the lifespan of naturally aging mice. Inflammopharmacology. 2019;27(6):1319–1323.
   Web of Science ®Google Scholar
• Boudreau RM, Johnson M, Veile R, et al. Impact of tranexamic acid on coagulation and inflammation in murine models of traumatic brain injury and hemorrhage. J Surg Res. 2017;215:47–54.
   Web of Science ®Google Scholar
• Asimakopoulos G, Thompson R, Nourshargh S, et al. An anti-inflammatory property of aprotinin detected at the level of leukocyte extravasation. J Thorac Cardiovasc Surg. 2000;120(2):361–369.
   Web of Science ®Google Scholar
• Reichel CA, Lerchenberger M, Uhl B, et al. Plasmin inhibitors prevent leukocyte accumulation and remodeling events in the postischemic microvasculature. PLoS One. 2011;6(2):e17229.
   Web of Science ®Google Scholar
• Yoshino T, Kimoto A, Kobayashi S, et al. Pharmacological profile of celecoxib, a specific cyclooxygenase-2 inhibitor. Arzneimittelforschung. 2005;55(7):394–402.
   Web of Science ®Google Scholar
• Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods. 1984;11:47–60.
   PubMed Web of Science ®Google Scholar
• Hiramoto K, Sugiyama D, Takahashi Y, Mafune E. The amelioration effect of tranexamic acid in wrinkles induced by skin dryness. Biomed Pharmacother. 2016;80:16–22.
   PubMed Web of Science ®Google Scholar
• Monji A. The neuroinflammation hypothesis of psychiatric disorders. Psychiatria Et Neurologia Japonica. 2012;114(2):124–133.
   Google Scholar
• Hanisch UK, Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci. 2007;10(11):1387–1394.
   PubMed Web of Science ®Google Scholar
• Hwang J, Zheng LT, Ock J, et al. Inhibition of glial inflammatory activation and neurotoxicity by tricycle antidepressants. Neuropharmacology. 2008;55(5):826–834.
   Web of Science ®Google Scholar
• Lim CM, Kim SW, Park JY, et al. Fluoxetine affords robust neuroprotection in the postischemic brain via its anti-inflammatory effect. J Neurosci Res. 2009;87(4):1037–1045.
   PubMed Web of Science ®Google Scholar
• O’Sullivan JB, Ryan KM, Curtin NM, Harkin A, Connor TJ. Noradrenaline reuptake inhibitors limit neuroinflammation in rat cortex following a systemic inflammatory challenge: implications for depression and neurodegeneration. Int J Neuropsychopharmacol. 2009;12(5):687–699.
   Web of Science ®Google Scholar
• Buntinx M, Moreels M, Vandenabeele F, et al. Cytokine-induced cell death in human oligodendroglial cell lines: I. Synergistic effects of IFN-gamma and TNF-alpha on apoptosis. J Neurosci Res. 2004;76(6):834–845.
   Web of Science ®Google Scholar
• Buntinx M, Gielen E, Van Hummelen P, et al. Cytokine-induced cell death in human oligodendroglial cell lines. II: alterations in gene expression induced by interferon-gamma and tumor necrosis factor-alpha. J Neurosci Res. 2004;76(6):846–861.
   Web of Science ®Google Scholar
• Leonard BE. Inflammation, depression and dementia: are they connected? Neurochem Res. 2007;32(10):1749–1756.
   PubMed Web of Science ®Google Scholar
• Caraci F, Copani A, Nicoletti F, Depression DF. Alzheimer’s disease: neurobiological links and common pharmacological targets. Eur J Pharmacol. 2010;626(1):64–71.
   Web of Science ®Google Scholar
• Shimizu T, Marusawa H. Role of inflammation in the development of gastrointestinal cancers. Nihon Shokakibyo Gakkai Zasshi. 2011;108(8):1374–1382.
   Google Scholar
• Neurath MF, Finotto SIL. 6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer. Cytokine Growth Factor Rev. 2011;22(2):83–89.
   PubMed Web of Science ®Google Scholar
• Ng WC, Jerath A, Wasowicz M. Tranexamic acid: a clinical review. Anaesthesiol Intensive Ther. 2015;47(4):339–350.
   PubMed Web of Science ®Google Scholar
• Tsuji K, Aoki T, Tejima E, et al. Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia. Stroke. 2005;36(9):1954–1959.
   Web of Science ®Google Scholar
• Gong Y, Hart E, Shchurin A, Hoover-Plow J. Inflammatory macrophage migration requires MMP-9 activation by plasminogen in mice. J Clin Invest. 2008;118(9):3012–3024.
   PubMed Web of Science ®Google Scholar
• Li Q, Ke F, Zhang W, et al. Plasmin plays an essential role in amplification of psoriasiform skin inflammation in mice. PLoS One. 2011;6(2):e16483.
   Web of Science ®Google Scholar
• Kawanokuchi J, Mizuno T, Takeuchi H, et al. Production of interferon-gamma by microglia. Mult Scler. 2006;12(5):558–564.
   Web of Science ®Google Scholar
• Takeuchi H, Jin S, Wang J, et al. Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. J Biol Chem. 2006;281(30):21362–21368.
   PubMed Web of Science ®Google Scholar
• Takeda A, Yasuda T, Miyata T, et al. Advanced glycation end products co-localized with astrocytes and microglial cells in Alzheimer’s disease brain. Acta Neuropathol. 1998;95(6):555–558.
   Web of Science ®Google Scholar
• Ni J, Wu Z, Peterts C, et al. The critical role of proteolytic relay through cathepsins B and E in the phenotypic change of microglia/macrophage. J Neurosci. 2015;35(36):12488–12501.
   Web of Science ®Google Scholar
• Nakano T, Fujita H, Kikuchi N, Arita H. Plasmin converts pro-form of group I phospholipase A2 into receptor binding, active forms. Biochem Biophys Res Commun. 1994;198(1):10–15.
   PubMed Web of Science ®Google Scholar